共 20 条
- [1] Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance[J]. MOLECULAR CANCER THERAPEUTICS, 2016, 15 (10) : 2273 - 2281Chen, Ping论文数: 0 引用数: 0 h-index: 0机构: Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USA Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USALee, Nathan V.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA USA Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USAHu, Wenyue论文数: 0 引用数: 0 h-index: 0机构: Pfizer Worldwide Res & Dev, Drug Safety, San Diego, CA USA Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USAXu, Meirong论文数: 0 引用数: 0 h-index: 0机构: Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA USA Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USAFerre, Rose Ann论文数: 0 引用数: 0 h-index: 0机构: Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USA Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USALam, Hieu论文数: 0 引用数: 0 h-index: 0机构: Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA USA Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USABergqvist, Simon论文数: 0 引用数: 0 h-index: 0机构: Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA USA Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USASolowiej, James论文数: 0 引用数: 0 h-index: 0机构: Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA USA Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USADiehl, Wade论文数: 0 引用数: 0 h-index: 0机构: Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USA Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USAHe, You-Ai论文数: 0 引用数: 0 h-index: 0机构: Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USA Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USAYu, Xiu论文数: 0 引用数: 0 h-index: 0机构: Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USA Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USANagata, Asako论文数: 0 引用数: 0 h-index: 0机构: Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USA Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USAVanArsdale, Todd论文数: 0 引用数: 0 h-index: 0机构: Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA USA Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USAMurray, Brion W.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA USA Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA USA
- [2] Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial[J]. LANCET ONCOLOGY, 2016, 17 (04) : 425 - 439Cristofanilli, Massimo论文数: 0 引用数: 0 h-index: 0机构: Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USATurner, Nicholas C.论文数: 0 引用数: 0 h-index: 0机构: Inst Canc Res, London SW3 6JB, England Royal Marsden Hosp, London SW3 6JJ, England Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USABondarenko, Igor论文数: 0 引用数: 0 h-index: 0机构: City Multiple Discipline Clin Hosp 4, Dnipropetrovsk Med Acad, Dnepropetrovsk, Ukraine Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USARo, Jungsil论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Goyang Si, South Korea Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USAIm, Seock-Ah论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Canc Res Inst, Seoul, South Korea Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USAMasuda, Norikazu论文数: 0 引用数: 0 h-index: 0机构: NHO Osaka Natl Hosp, Osaka, Japan Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USAColleoni, Marco论文数: 0 引用数: 0 h-index: 0机构: Ist Europeo Oncol, Milan, Italy Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USADeMichele, Angela论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Ctr Epidemiol & Biostat, Philadelphia, PA 19104 USA Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USALoi, Sherene论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USAVerma, Sunil论文数: 0 引用数: 0 h-index: 0机构: Sunnybrook Odette Canc Ctr, Toronto, ON, Canada Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USAIwata, Hiroji论文数: 0 引用数: 0 h-index: 0机构: Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USAHarbeck, Nadia论文数: 0 引用数: 0 h-index: 0机构: Univ Munchen LMU, Brustzentrum, Munich, Germany Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USAZhang, Ke论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USATheall, Kathy Puyana论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Cambridge, MA USA Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USAJiang, Yuqiu论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USABartlett, Cynthia Huang论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Collegeville, PA USA Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USAKoehler, Maria论文数: 0 引用数: 0 h-index: 0机构: Pfizer, New York, NY USA Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USASlamon, Dennis论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Los Angeles, CA USA Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA
- [3] Palbociclib and Letrozole in Advanced Breast Cancer[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (20) : 1925 - 1936Finn, Richard S.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USA Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USAMartin, Miguel论文数: 0 引用数: 0 h-index: 0机构: Univ Complutense, Hosp Gregorio Maranon, Madrid, Spain Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USARugo, Hope S.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USAJones, Stephen论文数: 0 引用数: 0 h-index: 0机构: US Oncol Res, The Woodlands, TX USA Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USAIm, Seock-Ah论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Canc Res Inst, Seoul Natl Univ Hosp, Coll Med, Seoul, South Korea Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USAGelmon, Karen论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC, Canada Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USAHarbeck, Nadia论文数: 0 引用数: 0 h-index: 0机构: Univ Munchen LMU, Brustzentrum, Munich, Germany Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USALipatov, Oleg N.论文数: 0 引用数: 0 h-index: 0机构: State Budget Med Inst Republican Clin Oncol, Ufa, Russia Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USAWalshe, Janice M.论文数: 0 引用数: 0 h-index: 0机构: All Ireland Cooperat Oncol Res Grp, Dublin, Ireland Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USAMoulder, Stacy论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USAGauthier, Eric论文数: 0 引用数: 0 h-index: 0机构: Pfizer, La Jolla, CA USA Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USALu, Dongrui R.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, La Jolla, CA USA Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USARandolph, Sophia论文数: 0 引用数: 0 h-index: 0机构: Pfizer, La Jolla, CA USA Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USADieras, Veronique论文数: 0 引用数: 0 h-index: 0机构: Inst Curie, Paris, France Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USASlamon, Dennis J.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USA Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USA
- [4] The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study[J]. LANCET ONCOLOGY, 2015, 16 (01) : 25 - 35Finn, Richard S.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Los Angeles, CA USA Univ Calif Los Angeles, Los Angeles, CA USACrown, John P.论文数: 0 引用数: 0 h-index: 0机构: Irish Cooperat Oncol Res Grp, Dublin, Ireland Univ Calif Los Angeles, Los Angeles, CA USALang, Istvan论文数: 0 引用数: 0 h-index: 0机构: Orszagos Onkol Int, Budapest, Hungary Univ Calif Los Angeles, Los Angeles, CA USABoer, Katalin论文数: 0 引用数: 0 h-index: 0机构: Szent Margit Korhaz, Budapest, Hungary Univ Calif Los Angeles, Los Angeles, CA USABondarenko, Igor M.论文数: 0 引用数: 0 h-index: 0机构: City Multiple Discipline Clin Hosp 4, Dnipropetrovsk Med Acad, Dnepropetrovsk, Ukraine Univ Calif Los Angeles, Los Angeles, CA USAKulyk, Sergey O.论文数: 0 引用数: 0 h-index: 0机构: Municipal Treatment & Prophylact Inst, Donetsk, Ukraine Univ Calif Los Angeles, Los Angeles, CA USAEttl, Johannes论文数: 0 引用数: 0 h-index: 0机构: Tech Univ Munich, D-80290 Munich, Germany Univ Calif Los Angeles, Los Angeles, CA USAPatel, Ravindranath论文数: 0 引用数: 0 h-index: 0机构: Comprehens Blood & Canc Ctr, Bakersfield, CA USA Univ Calif Los Angeles, Los Angeles, CA USAPinter, Tamas论文数: 0 引用数: 0 h-index: 0机构: Petz Aladar Megyei Oktato Korhaz, Gyor, Hungary Univ Calif Los Angeles, Los Angeles, CA USASchmidt, Marcus论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Mainz, Mainz, Germany Univ Calif Los Angeles, Los Angeles, CA USAShparyk, Yaroslav论文数: 0 引用数: 0 h-index: 0机构: Lviv State Oncol Reg Treatment & Diagnost Ctr, Lvov, Ukraine Univ Calif Los Angeles, Los Angeles, CA USAThummala, Anu R.论文数: 0 引用数: 0 h-index: 0机构: Comprehens Canc Ctr Nevada, Las Vegas, NV USA Univ Calif Los Angeles, Los Angeles, CA USAVoytko, Nataliya L.论文数: 0 引用数: 0 h-index: 0机构: Kyiv City Clin Oncol Ctr, Kiev, Ukraine Univ Calif Los Angeles, Los Angeles, CA USAFowst, Camilla论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, Milan, Italy Univ Calif Los Angeles, Los Angeles, CA USAHuang, Xin论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, San Diego, CA USA Univ Calif Los Angeles, Los Angeles, CA USAKim, Sindy T.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, San Diego, CA USA Univ Calif Los Angeles, Los Angeles, CA USARandolph, Sophia论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, San Diego, CA USA Univ Calif Los Angeles, Los Angeles, CA USASlamon, Dennis J.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Los Angeles, CA USA Univ Calif Los Angeles, Los Angeles, CA USA
- [5] PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro[J]. BREAST CANCER RESEARCH, 2009, 11 (05)Finn, Richard S.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USADering, Judy论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USAConklin, Dylan论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USAKalous, Ondrej论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USACohen, David J.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USADesai, Amrita J.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USAGinther, Charles论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USAAtefi, Mohammad论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USAChen, Isan论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Pfizer Global Res & Dev, San Diego, CA 92121 USA Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USAFowst, Camilla论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Clin Dev, Pfizer Oncol BU, I-20152 Milan, Italy Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USALos, Gerret论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Pfizer Global Res & Dev, San Diego, CA 92121 USA Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USASlamon, Dennis J.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA
- [6] MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (32) : 3638 - +Goetz, Matthew P.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA论文数: 引用数: h-index:机构:Campone, Mario论文数: 0 引用数: 0 h-index: 0机构: Inst Cancerol Ouest, Angers, France Mayo Clin, 200 1st St SW, Rochester, MN 55905 USASohn, Joohyuk论文数: 0 引用数: 0 h-index: 0机构: Yonsei Canc Ctr, Seoul, South Korea Mayo Clin, 200 1st St SW, Rochester, MN 55905 USAPaluch-Shimon, Shani论文数: 0 引用数: 0 h-index: 0机构: Sheba Med Ctr, Ramat Gan, Israel Mayo Clin, 200 1st St SW, Rochester, MN 55905 USAHuober, Jens论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Ulm, Germany Mayo Clin, 200 1st St SW, Rochester, MN 55905 USAPark, In Hae论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Goyangsi, South Korea Mayo Clin, 200 1st St SW, Rochester, MN 55905 USATredan, Olivier论文数: 0 引用数: 0 h-index: 0机构: Ctr Leon Berard, Lyon, France Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA论文数: 引用数: h-index:机构:Manso, Luis论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ 12 Octubre, Madrid, Spain Mayo Clin, 200 1st St SW, Rochester, MN 55905 USAFreedman, Orit C.论文数: 0 引用数: 0 h-index: 0机构: Durham Reg Canc Ctr, Oshawa, ON, Canada Mayo Clin, 200 1st St SW, Rochester, MN 55905 USAJaliffe, Georgina Garnica论文数: 0 引用数: 0 h-index: 0机构: Grp Med CAMINO SC, Mexico City, DF, Mexico Mayo Clin, 200 1st St SW, Rochester, MN 55905 USAForrester, Tammy论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly, Indianapolis, IN USA Mayo Clin, 200 1st St SW, Rochester, MN 55905 USAFrenzel, Martin论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly, Indianapolis, IN USA Mayo Clin, 200 1st St SW, Rochester, MN 55905 USABarriga, Susana论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly, Madrid, Spain Mayo Clin, 200 1st St SW, Rochester, MN 55905 USASmith, Ian C.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly, Indianapolis, IN USA Mayo Clin, 200 1st St SW, Rochester, MN 55905 USABourayou, Nawel论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly, Paris, France Mayo Clin, 200 1st St SW, Rochester, MN 55905 USADi Leo, Angelo论文数: 0 引用数: 0 h-index: 0机构: Hosp Prato, Prato, Italy Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA
- [7] Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer[J]. ANNALS OF ONCOLOGY, 2018, 29 (07) : 1541 - 1547Hortobagyi, G. N.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USAStemmer, S. M.论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Inst Oncol, Davidoff Ctr, Rabin Med Ctr, Tel Aviv, Israel Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USABurris, H. A.论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst, Nashville, TN USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USAYap, Y. S.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USASonke, C. S.论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Med Oncol, Amsterdam, Netherlands BOOG Study Ctr, Amsterdam, Netherlands Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USAPaluch-Shimon, S.论文数: 0 引用数: 0 h-index: 0机构: Sheba Med Ctr, Div Oncol, Ramat Gan, Israel Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USACampone, M.论文数: 0 引用数: 0 h-index: 0机构: Inst Cancerol Ouest Rene Gauducheau, Dept Med Oncol, St Herblain, France Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USAPetrakova, K.论文数: 0 引用数: 0 h-index: 0机构: Masaryk Mem Canc Inst, Dept Comprehens Canc Care, Brno, Czech Republic Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USABlackwell, K. L.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Dept Med, Med Ctr, Durham, NC 27706 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USAWiner, E. P.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USAJanni, W.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Dept Gynecol, Ulm, Germany Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USAVerma, S.论文数: 0 引用数: 0 h-index: 0机构: Tom Baker Canc Clin, Dept Oncol, Calgary, AB, Canada Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USAConte, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy Univ Padua, Div Med Oncol, Padua, Italy IRCCS, Ist Oncol Veneto, Padua, Italy Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USAArteaga, C. L.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USACameron, D. A.论文数: 0 引用数: 0 h-index: 0机构: Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USAMondal, S.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, Med Oncol, E Hanover, NJ USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USASu, F.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, Med Oncol, E Hanover, NJ USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USAMiller, M.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, Med Oncol, E Hanover, NJ USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USAElmeliegy, M.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, Med Oncol, E Hanover, NJ USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USAGerma, C.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, Med Oncol, E Hanover, NJ USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USAO'Shaughnessy, J.论文数: 0 引用数: 0 h-index: 0机构: Baylor Charles A Sammons Canc Ctr, Texas Oncol, Dallas, TX USA US Oncol Res Network, Dallas, TX USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
- [8] Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (18) : 1738 - 1748Hortobagyi, G. N.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAStemmer, S. M.论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Rabin Med Ctr, Davidoff Ctr, Tel Aviv, Israel Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USABurris, H. A.论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst, Nashville, TN USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAYap, Y. -S.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Singapore, Singapore Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USASonke, G. S.论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Amsterdam, Netherlands BOOG Study Ctr, Amsterdam, Netherlands Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAPaluch-Shimon, S.论文数: 0 引用数: 0 h-index: 0机构: Sheba Med Ctr, Ramat Gan, Israel Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USACampone, M.论文数: 0 引用数: 0 h-index: 0机构: Inst Cancerol Ouest Rene Gauducheau, St Herblain, France Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USABlackwell, K. L.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Durham, NC USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA论文数: 引用数: h-index:机构:Winer, E. P.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAJanni, W.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Ulm, Germany Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAVerma, S.论文数: 0 引用数: 0 h-index: 0机构: Tom Baker Canc Clin, Calgary, AB, Canada Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAConte, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Padua, Padua, Italy Ist Ricovero & Cura Carattere Sci, Ist Oncol Veneto, Padua, Italy Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAArteaga, C. L.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Nashville, TN USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USACameron, D. A.论文数: 0 引用数: 0 h-index: 0机构: Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAPetrakova, K.论文数: 0 引用数: 0 h-index: 0机构: Masaryk Mem Canc Inst, Brno, Czech Republic Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAHart, L. L.论文数: 0 引用数: 0 h-index: 0机构: Florida Canc Specialists Sarah Cannon Res Inst, Ft Myers, WA, Australia Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAVillanueva, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Besancon, Besancon, France Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAChan, A.论文数: 0 引用数: 0 h-index: 0机构: Breast Canc Res Ctr Western Australia, Perth, WA, Australia Curtin Univ, Perth, WA, Australia Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAJakobsen, E.论文数: 0 引用数: 0 h-index: 0机构: Vejle Hosp, Dept Oncol, Vejle, Denmark Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USANusch, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USABurdaeva, O.论文数: 0 引用数: 0 h-index: 0机构: Arkhangelsk Clin Oncol Dispensary, Arkhangelsk, Russia Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAGrischke, E. -M.论文数: 0 引用数: 0 h-index: 0机构: Univ Tubingen, Tubingen, Germany Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAAlba, E.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen de la Victoria, Inst Biomed Res Malaga, Malaga, Spain Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAWist, E.论文数: 0 引用数: 0 h-index: 0机构: Oslo Univ Hosp, Oslo, Norway Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAMarschner, N.论文数: 0 引用数: 0 h-index: 0机构: Joint Practice Interdisciplinary Oncol & Hematol, Freiburg, Germany Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAFavret, A. M.论文数: 0 引用数: 0 h-index: 0机构: Virginia Canc Specialists, Arlington, VA USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAYardley, D.论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst, Nashville, TN USA Tennessee Oncol, Nashville, TN USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USABachelot, T.论文数: 0 引用数: 0 h-index: 0机构: Ctr Leon Berard, Lyon, France Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USATseng, L. -M.论文数: 0 引用数: 0 h-index: 0机构: Natl Yang Ming Univ, Taipei Vet Gen Hosp, Taipei, Taiwan Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USABlau, S.论文数: 0 引用数: 0 h-index: 0机构: Northwest Med Specialties, Rainier Hematol Oncol, Puyallup, WA USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAXuan, F.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USASouami, F.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, Basel, Switzerland Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAMiller, M.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAGerma, C.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAHirawat, S.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAO'Shaughnessy, J.论文数: 0 引用数: 0 h-index: 0机构: Baylor Charles A Sammons Canc Ctr, Texas Oncol, Dallas, TX USA US Oncol Network, Dallas, TX USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
- [9] Evolving options for the treatment of metastatic breast cancer: Progression-free survival as an endpoint[J]. CANCER TREATMENT REVIEWS, 2011, 37 (07) : 495 - 504Hurvitz, Sara A.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Dept Med, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Dept Med, Los Angeles, CA 90095 USA
- [10] Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (04) : 307 - 316Im, S. -A.论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South Korea Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaLu, Y. -S.论文数: 0 引用数: 0 h-index: 0机构: Natl Taiwan Univ Hosp, Taipei, Taiwan Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaBardia, A.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA Harvard Med Sch, Boston, MA 02115 USA Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaHarbeck, N.论文数: 0 引用数: 0 h-index: 0机构: Ludwig Maximilians Univ Munchen, Breast Ctr, Dept Obstet & Gynecol, Munich, Germany Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaColleoni, M.论文数: 0 引用数: 0 h-index: 0机构: Ist Europeo Oncol, Div Med Senol, Milan, Italy Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaFranke, F.论文数: 0 引用数: 0 h-index: 0机构: Hosp Caridade Ijui, CACON, Ijui, Brazil Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaChow, L.论文数: 0 引用数: 0 h-index: 0机构: Org Oncol & Translat Res, Hong Kong, Peoples R China Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaSohn, J.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Seoul, South Korea Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaLee, K. -S.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Ctr Breast Canc, Gyeonggi Do, South Korea Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaCampos-Gomez, S.论文数: 0 引用数: 0 h-index: 0机构: Inst Seguridad Social Estado Mexico & Municipios, Ctr Oncol Estatal, Toluca, Mexico Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaVillanueva-Vazquez, R.论文数: 0 引用数: 0 h-index: 0机构: Hosp St Joan Despi Moises Broggi, Inst Catala Oncol, Barcelona, Spain Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaJung, K. -H.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaChakravartty, A.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaHughes, G.论文数: 0 引用数: 0 h-index: 0机构: Novartis, Basel, Switzerland Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaGounaris, I.论文数: 0 引用数: 0 h-index: 0机构: Novartis, Basel, Switzerland Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaRodriguez-Lorenc, K.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaTaran, T.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaHurvitz, S.论文数: 0 引用数: 0 h-index: 0机构: UCLA, Ctr Comprehens Canc, Los Angeles, CA USA Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South KoreaTripathy, D.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South Korea